NGL Fine-Chem Limited (BOM:524774)
India · Delayed Price · Currency is INR 3,201.05
-16.45 (-0.51%)
At close: Jul 9, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 19.7 billion as of July 10, 2026. Its market cap has increased by 217.95% in one year.
Market Cap
19.70B
Enterprise Value
20.35B
Revenue
5.01B
Ranking
n/a
PE Ratio
40.94
Stock Price
3,201.05
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 19.70B, an increase of 24,406.16%. That is a compound annual growth rate of 29.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 19.70B | 126.34% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 116.32B |
| Suven Life Sciences | 83.69B |
| IOL Chemicals and Pharmaceuticals | 48.93B |
| Gujarat Themis Biosyn | 39.88B |
| Sai Parenteral's | 25.91B |
| Bajaj HealthCare | 11.23B |
| Shree Ganesh Remedies | 8.87B |
| Anlon Healthcare | 8.07B |